Sign In
Buy BLCO
$14.87
-0.110 (-0.734%)
At Close: Jun 03, 2026
NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bausch Lomb Corporation ("Bausch Lomb Corporation") (NYSE:BLCO) concerni
NEW YORK CITY, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb ("Bausch & Lomb" or "the Company")
Bausch Lomb Corporation (BLCO) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
03:15pm, Friday, 28'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bausch Lomb Corporation ("Bausch Lomb Corporation") (NYSE:BLCO) concerni
NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb ("Bausch & Lomb" or "the Company")
Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30
07:45am, Wednesday, 26'th Mar 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter
Bausch + Lomb Corporation (BLCO) Q4 2024 Earnings Call Transcript
12:19pm, Wednesday, 19'th Feb 2025
Bausch + Lomb Corporation (NYSE:BLCO ) Q4 2024 Results Conference Call February 19, 2025 8:00 AM ET Company Participants George Gadkowski - Vice President of Investor Relations Brent Saunders - CEO &
Bausch + Lomb (BLCO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
10:35am, Wednesday, 19'th Feb 2025
While the top- and bottom-line numbers for Bausch + Lomb (BLCO) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics
Bausch & Lomb to shake up contact lenses with deal off the table
09:16am, Wednesday, 19'th Feb 2025
Bausch & Lomb said this month it had explored taking the company private with a third-party buyer. No deal was reached as a consortium of private equity firms TPG and Blackstone reportedly backed out.
Bausch + Lomb (BLCO) Surpasses Q4 Earnings and Revenue Estimates
09:05am, Wednesday, 19'th Feb 2025
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.24 per share a year ago.
Unlocking Q4 Potential of Bausch + Lomb (BLCO): Exploring Wall Street Estimates for Key Metrics
10:21am, Monday, 17'th Feb 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Bausch + Lomb (BLCO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for
Bausch Health Provides Update on Strategic Alternatives
07:05am, Thursday, 06'th Feb 2025
LAVAL, QC / ACCESS Newswire / February 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives throu
Bausch and Lomb CEO: Right on track with our important initiatives
12:24pm, Tuesday, 14'th Jan 2025
Brent Saunders, Bausch and Lomb CEO, joins 'Money Movers' to discuss how Saunders has changed the portfolio in his time as chief executive, what the growth is like for Bausch and Lomb, and much more.
Bausch + Lomb Corporation (BLCO) Q3 2024 Earnings Call Transcript
03:12pm, Wednesday, 30'th Oct 2024
Bausch + Lomb Corporation (NYSE:BLCO ) Q3 2024 Results Conference Call October 30, 2024 8:00 AM ET Company Participants George Gadkowski - Vice President of Investor Relations and Business Insights Br
Bausch + Lomb (BLCO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10:36am, Wednesday, 30'th Oct 2024
The headline numbers for Bausch + Lomb (BLCO) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Stree
Bausch + Lomb (BLCO) Q3 Earnings and Revenues Top Estimates
09:16am, Wednesday, 30'th Oct 2024
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.22 per share a year ago.
